John Patrick Carey

John Patrick Carey

Auto-generated profile, based on publicly available information

John Patrick Carey

Department of Otolaryngology–Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2008 in Experimental Brain Research
Verified
Journal Article
Closed access
PDF file
AMAmerico A. Migliaccio
Americo A. Migliaccio
LMLloyd B. Minor
Lloyd B. Minor
JCJohn P. Carey
John P. Carey

20 December 2022 in Journal of the Association for Research in Otolaryngology
Verified
Journal Article
Closed access
PDF file
LSLeo Shen
Leo Shen
NANicholas S. Andresen
Nicholas S. Andresen
DCDivya A. Chari
Divya A. Chari
JPJacob M. Pogson
Jacob M. Pogson
ALAmanda M. Lauer
Amanda M. Lauer
Bryan K WardBryan K Ward
Bryan K Ward

1 June 2018 in Otology & Neurotology
Verified
Journal Article
Closed access
PDF file
GAGodwin Abiola
Godwin Abiola
Bryan K WardBryan K Ward
Bryan K Ward
SBStephen Bowditch
Stephen Bowditch
EREva Katharina Ritzl
Eva Katharina Ritzl
JCJohn Patrick Carey
John Patrick Carey
Objective: Cochlear implants are generally considered a contraindication for any procedure requiring electrical stimulation near the implant. We present a case of a patient undergoing intraoperative transcranial electrical motor-evoked potential monitoring with a cochlear implant without adverse outcomes. Patient: A 12-year-old girl with a history of VACTERL presented with worsening congenital kyphosis and bilateral severe-to-profound hearing loss. Since age 7 the patient used a cochlear implant in the right ear and hearing aid in the left ear. Physical examination and magnetic resonance imaging in 2016 revealed a left-sided 66-degree thoracolumbar kyphosis at T11 making the patient a candidate for surgical correction. Interventions: She underwent a posterior spinal fusion surgery, performed with intraoperative transcranial electrical motor-evoked potential monitoring. Steps were taken to mitigate electrical stimulation of the patient's cochlear implant. Main Outcome Measures: Postoperative impedance of individual channels, audiometry, and neural response testing were compared with preoperative measurements. Results: Significant (>10%) impedance changes were observed postoperatively in channels 1, 2, 4, and 6; however, the net variation across all the channels was low (3%). The patient reported no hearing changes, and no significant changes in hearing threshold were seen in postoperative audiometric testing or neural response testing. Conclusion: We present a case of successful posterior spinal fusion with intraoperative neurophysiological monitoring via transcranial electrical stimulation, in a patient with a cochlear implant. With proper precautions, motor-evoked potential monitoring can be safely performed in a patient with a cochlear implant.

19 May 2017 in Cureus
Verified
Journal Article
Open access
PDF file
SPSeth E Pross
Seth E Pross
JSJeffrey D. Sharon
Jeffrey D. Sharon
MLMichael Lim
Michael Lim
AMAbhay Moghekar
Abhay Moghekar
ARAruna Rao
Aruna Rao
JCJohn P. Carey
John P. Carey
While infrequent, cerebrospinal fluid (CSF) leaks are known to occur after surgical resection of vestibular schwannomas. Early signs of CSF leak often include headache and altered mental status. If untreated, life-threatening complications can occur, including brainstem herniation and meningitis. The appropriate surgical treatment for a CSF leak requires accurate localization of the source. While the most likely location of a CSF leak after lateral skull base surgery is through the aerated portions of the temporal bone, we present a unique case of a man with a prolonged CSF leak after an acoustic tumor removal who was ultimately found to have an occult spinal perineural (Tarlov) cyst as the source. Accurate localization was ultimately achieved with CT myelogram after empirically obliterating his mastoid failed to restore intracranial CSF volume. Tarlov cysts are the most common cause of idiopathic intracranial hypotension, and this case highlights the importance of considering this entity in the differential diagnosis of postoperative CSF leaks.

19 February 2013 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
JCJ.P. Carey
J.P. Carey
Bryan K WardBryan K Ward
Bryan K Ward
JRJ.J. Rosowski
J.J. Rosowski
LML.B. Minor
L.B. Minor

18 June 2023
Verified
Dataset
Closed access
PDF file
PKPavan S. Krishnan
Pavan S. Krishnan
FZFernando T. Zamuner
Fernando T. Zamuner
CJCarolyn M. Jenks
Carolyn M. Jenks
JXJohnny Y. Xie
Johnny Y. Xie
LZLisa Zhang
Lisa Zhang
JCJohn P. Carey
John P. Carey
Calcitonin gene-related peptide (CGRP) is a vasoactive neuropeptide that plays a putative role in the pathophysiology of migraine headaches and may be a candidate for biomarker status. CGRP is released from neuronal fibers upon activation and induces sterile neurogenic inflammation and arterial vasodilation in the vasculature that receives trigeminal efferent innervation. The presence of CGRP in the peripheral vasculature has spurred investigations to detect and quantify this neuropeptide in human plasma using proteomic assays, such as the enzyme-linked immunosorbent assay (ELISA). However, its half-life of 6.9 min and the variability in technical details of assay protocols, which are often not fully described, have yielded inconsistent CGRP ELISA data in the literature. Here, a modified ELISA protocol for the purification and quantification of CGRP in human plasma is presented. The procedural steps involve sample collection and preparation, extraction using a polar sorbent as a means of purification, additional steps to block non-specific binding, and quantification via ELISA. Further, the protocol has been validated with spike and recovery and linearity of dilution experiments. This validated protocol can theoretically be used to quantify CGRP concentrations in the plasma of individuals not only with migraine, but also with other diseases in which CGRP may play a role.